| Elizabeth Patricia Mccadden, PHD | |
|
1032 Crosswinds Ct, Wentzville, MO 63385-4836 | |
| (888) 403-1071 | |
| Not Available |
| Full Name | Elizabeth Patricia Mccadden |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 1032 Crosswinds Ct, Wentzville, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851943328 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 2019022778 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Patricia Mccadden, PHD 1800 Community, Clinton, MO 64735-8804 Ph: (660) 885-8131 | Elizabeth Patricia Mccadden, PHD 1032 Crosswinds Ct, Wentzville, MO 63385-4836 Ph: (888) 403-1071 |
News Archive
CorMatrix Cardiovascular, Inc., a medical device company dedicated to developing and delivering unique extracellular matrix (ECM) biomaterial devices that harness the body's innate ability to repair damaged cardiovascular tissue, today announced that the Company has been awarded $2.3 million in grants under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program to advance the development of their unique ECM technology.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that it received a Complete Response Letter from the U.S. Food and Drug Administration regarding its New Drug Application for APF530 in the prevention of both acute and delayed onset chemotherapy-induced nausea and vomiting.
D-Pharm Ltd announced enrollment of patients with acute ischemic stroke into its Phase III clinical study of DP-b99 (MACSI). The first patient has been enrolled at the Wolfson Medical Center, Israel. The MACSI trial involves numerous medical centers in the US, Canada, Europe, Israel, South Africa, South Korea and Brazil. DP-b99 is D-Pharm's most advanced product developed for protection of brain cells suffering from restricted blood and oxygen supply (ischemia).
Researchers at St. Michael's Hospital have identified how natural killer cells in the mouse placenta can cause a fetus to fail to grow in the womb or cause miscarriages.
On the U.S. Global Leadership Coalition (USGLC) blog, Ashley Chandler, deputy policy director at the USGLC, discusses USAID's new guidance on Building Resilience to Recurrent Crisis, writing that the policy "is about using existing development dollars more effectively in disaster prone regions, so that less humanitarian assistance is needed in the future."
› Verified 4 days ago
Fatemeh Akbari, PLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1032 Crosswinds Ct, Wentzville, MO 63385 Phone: 844-853-8937 | |
Andrew Peter Wislocki, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1032 Crosswinds Ct, Wentzville, MO 63385 Phone: 888-403-1071 | |
Dr. Ursula Wiese Marsh, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 219 Creekside Office Drive, Wentzville, MO 63385 Phone: 636-357-0136 Fax: 636-639-1004 | |
Chandler Puhy, LP Psychologist Medicare: Medicare Enrolled Practice Location: 1032 Crosswinds Ct, Wentzville, MO 63385 Phone: 844-853-8937 | |
Cynthia L Mueller, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1032 Crosswinds Ct, Wentzville, MO 63385 Phone: -- | |
Kayla Elayne Campbell, PHD, PLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1032 Crosswinds Ct, Wentzville, MO 63385 Phone: 844-853-8937 | |
Rosemarie Kugler, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1032 Crosswinds Ct, Wentzville, MO 63385 Phone: 888-403-1071 |